hPSC-CMs

human pluripotent stem cell-derived cardiomyocytes · HELP Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hPSC-CMs, covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Treating Heart Failure With hPSC-CMs [Phase 1, Phase 2]